Previous close | 1.7350 |
Open | 1.6195 |
Bid | 1.6000 x N/A |
Ask | 1.7000 x N/A |
Day's range | 1.6000 - 1.6299 |
52-week range | 1.4250 - 5.7000 |
Volume | |
Avg. volume | 1,134,998 |
Market cap | 7.513M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Successful first regulatory interaction with the Federal Agency for Medicines and Health Products (FAHMP) And Internal Debt Restructuring First regulatory agency interaction results in recommendation to commence Phase I/II Clinical Trial in NASH Patients LONDON, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Genflow Biosciences Plc (“Genflow” or “the Company”) (LSE:GENF) (OTCQB:GENFF), today announced the receipt of written comments from the Federal Agency for Medicines and Health Products (FAHMP) of Belgiu
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER NOW AT: https://bit.ly/3p8LhIP It is recommended that investors pre-register and run the online system check to exped
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.comLONDON, June 20, 2023 (GLOBE NEWSWIRE) -- Genflow Biosciences (OTCQB:GENFF), a biotechnology company based in the UK, focused on longevity, today announced that Dr. Eric Leire, CEO, will present live at the Life Science Investors Forum, hosted by VirtualInvestorConferences.com, on June 22nd , 2023. DATE: June 22nd ,2023TIME: 11:00amLINK: https:/